These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209 [TBL] [Abstract][Full Text] [Related]
4. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations. Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149 [TBL] [Abstract][Full Text] [Related]
5. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage. Montefiori LE; Mullighan CG Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving Bendig S; Stengel A; Walter W; Meggendorfer M; Baer C; Müller ML; Haferlach T; Kern W; Haferlach C Leuk Lymphoma; 2022 Mar; 63(3):747-750. PubMed ID: 34738838 [No Abstract] [Full Text] [Related]
7. A novel t(6;14)(q25-q27;q32) in acute myelocytic leukemia involves the BCL11B gene. Bezrookove V; van Zelderen-Bhola SL; Brink A; Szuhai K; Raap AK; Barge R; Beverstock GC; Rosenberg C Cancer Genet Cytogenet; 2004 Feb; 149(1):72-6. PubMed ID: 15104287 [TBL] [Abstract][Full Text] [Related]
8. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation. Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744 [TBL] [Abstract][Full Text] [Related]
12. Role of the transcription factor Bcl11b in development and lymphomagenesis. Kominami R Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536 [TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a child with T/myeloid acute bilineal leukemia associated with TLX3/BCL11B fusion and 9q deletion. Oliveira JL; Kumar R; Khan SP; Law ME; Erickson-Johnson M; Oliveira AM; Ketterling RP; Dogan A Pediatr Blood Cancer; 2011 Mar; 56(3):467-9. PubMed ID: 21225930 [TBL] [Abstract][Full Text] [Related]
19. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma. Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541 [TBL] [Abstract][Full Text] [Related]
20. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele. Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]